Navigation Links
Advanced Health Media Further Expands Investment in Regulatory Compliance; Company Announces Ms. Susan Y. Leonard as Chief Compliance Officer
Date:9/22/2010

BRIDGEWATER, N.J., Sept. 22 /PRNewswire/ -- Today, Advanced Health Media, LLC (AHM), announced the appointment of Ms. Susan Y. Leonard as Chief Compliance Officer. Ms. Leonard will lead the company's initiatives dedicated to understanding and communicating regulatory governance associated with the pharmaceutical, biotechnology and medical device markets.

"Susan's extensive regulatory experience in our industry will further strengthen AHM's current position as a leader in compliance-related services and solutions. She will contribute significantly to our ability to proactively address client's needs as laws change," stated Jeff Brady, President and Chief Executive Officer of AHM.

Ms. Leonard brings with her more than 13 years of legal and regulatory experience in the healthcare and pharmaceutical industry, serving six of those years as in-house regulatory counsel at Schering Plough and Daiichi Sankyo, Inc. She has spent considerable time examining and addressing current aggregate-spend compliance mandates and related state and federal regulations. In addition, she has extensive experience working with the federal Anti- kickback Statute, False Claims Act, Foreign Corrupt Practice Act, HIPAA and the Prescription Drug Marketing Act. Ms. Leonard has led initiatives focused on the evaluation and communication of matters associated with PhRMA Code compliance and adherence to the OIG Guidance on Interactions with Healthcare Professionals.

"Susan's contribution will be significant for the Compliance Solutions division," said Kim Mills, General Manager and Sr. Vice President of AHM's Compliance Solutions. "Her extensive regulatory exposure, as well as her first-hand understanding of our client's needs, will help us help our clients prepare to address current—and pending—legislation regarding promotional spend on healthcare providers."

Prior to serving as in-house counsel, Ms. Leonard was partner at Brach Eichler law firm and associate at Lowenstein Sandler. She holds an M.A. degree from New York University Graduate School of Arts and Sciences and a J.D. from Rutgers Law School.

About Advanced Health Media, LLC

Advanced Health Media (AHM) is the leading U.S. provider of speaker-led meeting logistics, state and federal regulatory compliance technology, thought leader development and medical communications. AHM has developed and markets a fully integrated suite of hosted technology solutions and sales support services designed to address the diverse operational and compliance management needs of its clients, including corporate speaker bureau and event management solutions, sales force automation technology, customer relationship management, and compliance tracking and reporting systems.  AHM also provides full-service medical communications, including strategic communication strategy, publication planning, scientific meetings and key opinion leader advocacy development. AHM provides services to more than 50 companies in the pharmaceutical sector.

Headquartered in Bridgewater, NJ, with offices in Union and Somerville, NJ, Chesapeake, VA and Chicago, IL, AHM is the parent company of AHM Solutions, Centeon Solutions, Embryon, LLC, Ephikacy, LLC, Cogenix, LLC, ProMedix, LLC, and InsiteResearch, LLC. For more information, please visit the AHM Web site at www.ahmdirect.com.


'/>"/>
SOURCE Advanced Health Media, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 ... of the "Structural Electronics 2015-2025: Applications, Technologies, ... In-Mold Electronics, Smart Skin, ... Photovoltaics Structural electronics involves electronic ... load-bearing, protective structures, replacing dumb structures such as ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
Breaking Medicine Technology:
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
Breaking Medicine News(10 mins):